According to Bloomberg, Sanofi has lined up a takeover target as it seeks to address its lowest valuation in pharma. The potential deal would be the pharmaceutical industry’s biggest takeover in years.
According to Bloomberg, Sanofi has lined up a takeover target as it seeks to address its lowest valuation in pharma. The potential deal would be the pharmaceutical industry’s biggest takeover in years.